Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997

Preventive Medicine

Volumn 31, Issue 3, 2000, Pages 195-202

  McDavid, Kathleen ^a   Melnik, Thomas A ^b   Derderian, Hrak ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Digital rectal exam; Prostate cancer; Prostate specific antigen test; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL EXAMINATION; FAMILY HISTORY; HEALTH PROMOTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; UNITED STATES;

EID: 0033856167     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.2000.0709     Document Type: Article

References (39)

1. Cancer statistics, 2000
2. The fall in incidence of prostate carcinoma
3. The epidemiology of prostate cancer part I: Descriptive epidemiology
4. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society
5. The value of the measurement of serum prostate-specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer
6. Evaluation of prostate-specific antigen and prostatic acid phosphatase as prostate cancer markers
7. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
8. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer
9. Serum prostate-specific antigen values in men with histologically confirmed benign prostatic hyperplasia versus patients with organ-confined prostate cancer
10. What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker
11. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute
12. Knowledge, attitudes, and screening practices among older men regarding prostate cancer
13. Sampling methods for random digit dialing
14. Improving data quality in a sample survey
15. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society
16. The impact of informed consent on patient interest in prostate specific antigen screening
17. Sons of men with prostate cancer: Their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing
18. Family history and the risk of prostate cancer
19. Familial patterns of prostate cancer: A case-control analysis
20. Family history and prostate cancer risk in black, white, and asian men in the United States and Canada
21. Changes in prostate cancer incidence and treatment in USA
22. Determination of prostate-specific antigen in serum by immunoradiometric assay
23. Concordance of self-reported data and medical record audit for six cancer screening procedures
24. Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non-Hispanic white health plan members in northern California
25. Measuring the use of mammography: Two methods compared
26. The accuracy of patient reports of a family history of cancer
27. The reliability of recollections of family history: Implications for the medical provider